2019 Q4 Form 10-K Financial Statement

#000114036120004374 Filed on February 28, 2020

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2019 Q2
Revenue $122.1M $117.3M $126.4M
YoY Change 4.06% 3.65% 9.8%
Cost Of Revenue $95.10M $89.90M $94.90M
YoY Change 3.26% 3.21% 7.96%
Gross Profit $26.96M $27.37M $31.43M
YoY Change 6.9% 4.97% 15.73%
Gross Profit Margin 22.08% 23.34% 24.87%
Selling, General & Admin $11.70M $10.56M $11.53M
YoY Change 12.5% -0.82% 13.81%
% of Gross Profit 43.4% 38.56% 36.68%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.720M $2.420M $2.560M
YoY Change 12.4% -2.02% 6.67%
% of Gross Profit 10.09% 8.84% 8.15%
Operating Expenses $11.70M $10.56M $11.53M
YoY Change 11.43% -0.82% 13.81%
Operating Profit $15.29M $16.82M $19.90M
YoY Change 3.26% 8.96% 16.87%
Interest Expense -$800.0K $557.0K $607.0K
YoY Change 166.67% -3.8% 11.38%
% of Operating Profit -5.23% 3.31% 3.05%
Other Income/Expense, Net $5.220M
YoY Change
Pretax Income $14.40M $16.27M $25.12M
YoY Change -11.66% 9.39% 52.2%
Income Tax $2.400M $3.197M $5.318M
% Of Pretax Income 16.67% 19.65% 21.17%
Net Earnings $7.900M $9.047M $14.62M
YoY Change -24.04% 11.66% 58.12%
Net Earnings / Revenue 6.47% 7.72% 11.57%
Basic Earnings Per Share
Diluted Earnings Per Share $617.2K $703.1K $1.141M
COMMON SHARES
Basic Shares Outstanding 12.77M 12.77M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q4 2019 Q3 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $23.50M $27.90M $34.90M
YoY Change 0.43% -13.35% 28.78%
Cash & Equivalents $23.55M $27.86M $34.86M
Short-Term Investments
Other Short-Term Assets $5.787M $7.098M $7.102M
YoY Change 32.94% 44.86% 36.58%
Inventory
Prepaid Expenses
Receivables $46.23M $47.12M $44.92M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $85.39M $92.53M $107.0M
YoY Change 7.79% 2.02% 23.85%
LONG-TERM ASSETS
Property, Plant & Equipment $22.09M $21.37M $20.02M
YoY Change 9.52% 6.86% 1.63%
Goodwill $317.7M $316.6M $303.5M
YoY Change 8.23%
Intangibles $52.59M $53.39M $50.06M
YoY Change 7.7%
Long-Term Investments
YoY Change
Other Assets $1.519M $1.470M $1.445M
YoY Change 6.22% 5.0% 3.21%
Total Long-Term Assets $545.1M $468.3M $453.8M
YoY Change 49.78% 28.55% 28.17%
TOTAL ASSETS
Total Short-Term Assets $85.39M $92.53M $107.0M
Total Long-Term Assets $545.1M $468.3M $453.8M
Total Assets $630.5M $560.8M $560.8M
YoY Change 42.27% 23.26% 27.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.500M $2.900M $2.400M
YoY Change 25.0% 38.1% 41.18%
Accrued Expenses $30.86M $33.57M $31.35M
YoY Change -19.84% -16.28% -11.45%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $728.0K $718.0K $690.0K
YoY Change -49.23% -85.04% -85.63%
Total Short-Term Liabilities $60.56M $62.80M $57.02M
YoY Change 44.38% 33.61% 36.09%
LONG-TERM LIABILITIES
Long-Term Debt $50.36M $55.29M $66.32M
YoY Change 31.14% 1.08% 17.17%
Other Long-Term Liabilities $141.0K $718.0K $566.0K
YoY Change -82.99% -73.41% -79.04%
Total Long-Term Liabilities $50.50M $56.01M $66.88M
YoY Change 28.73% -2.42% 12.79%
TOTAL LIABILITIES
Total Short-Term Liabilities $60.56M $62.80M $57.02M
Total Long-Term Liabilities $50.50M $56.01M $66.88M
Total Liabilities $181.4M $188.1M $192.9M
YoY Change 96.42% -22.64% -15.73%
SHAREHOLDERS EQUITY
Retained Earnings $184.4M $181.1M $176.6M
YoY Change 10.13%
Common Stock $150.0K $150.0K $149.0K
YoY Change 0.67%
Preferred Stock
YoY Change
Treasury Stock (at cost) $31.63M $31.63M $31.63M
YoY Change 0.0%
Treasury Stock Shares $2.215M $2.215M $2.215M
Shareholders Equity $240.3M $235.5M $229.3M
YoY Change
Total Liabilities & Shareholders Equity $560.8M $565.2M $557.0M
YoY Change 26.55% 24.22% 26.45%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2019 Q2
OPERATING ACTIVITIES
Net Income $7.900M $9.047M $14.62M
YoY Change -24.04% 11.66% 58.12%
Depreciation, Depletion And Amortization $2.720M $2.420M $2.560M
YoY Change 12.4% -2.02% 6.67%
Cash From Operating Activities $15.99M $17.84M $15.06M
YoY Change -15.84% -23.73% -0.2%
INVESTING ACTIVITIES
Capital Expenditures -$2.760M -$2.550M -$2.380M
YoY Change 46.81% 25.0% 27.27%
Acquisitions $30.60M
YoY Change 86.94%
Other Investing Activities -$3.260M -$4.170M -$18.24M
YoY Change 2073.33% -42.16% 118.44%
Cash From Investing Activities -$6.020M -$6.730M -$20.61M
YoY Change 196.55% -27.24% 101.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -14.27M -18.12M 20.17M
YoY Change -44.78% 100.22% 716.6%
NET CHANGE
Cash From Operating Activities 15.99M 17.84M 15.06M
Cash From Investing Activities -6.020M -6.730M -20.61M
Cash From Financing Activities -14.27M -18.12M 20.17M
Net Change In Cash -4.300M -7.010M 14.62M
YoY Change -51.52% -237.72% 99.18%
FREE CASH FLOW
Cash From Operating Activities $15.99M $17.84M $15.06M
Capital Expenditures -$2.760M -$2.550M -$2.380M
Free Cash Flow $18.75M $20.39M $17.44M
YoY Change -10.2% -19.82% 2.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q4 us-gaap Business Acquisition Percentage Of Voting Interests Acquired
BusinessAcquisitionPercentageOfVotingInterestsAcquired
0.35
CY2018Q2 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
19835000
CY2019Q2 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
31330000
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2019Q2 dei Entity Public Float
EntityPublicFloat
778600000
CY2019 dei Entity Registrant Name
EntityRegistrantName
U S PHYSICAL THERAPY INC /NV
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0000885978
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12774600
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019 dei Entity Small Business
EntitySmallBusiness
false
CY2019Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2494000
CY2018Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2019000
CY2019Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
9823000
CY2018Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
6742000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
44751000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
46228000
CY2018Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
3124000
CY2019Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
2277000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
38493000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30855000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
66099000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
64154000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
87383000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
80028000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5032000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6985000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5939000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2672000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2698000
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2777000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3015000
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2654000
CY2018Q4 us-gaap Assets
Assets
443166000
CY2019Q4 us-gaap Assets
Assets
560845000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
79214000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
85386000
CY2019Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
3639000
CY2018Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
305000
CY2017Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
1527000
CY2019Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
2604000
CY2018Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
1633000
CY2017Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
5853000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14989337
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14899233
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2017Q4 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
46722000
CY2017Q4 us-gaap Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value
BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
10282000
CY2017Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
-2865000
CY2018Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
-525000
CY2019Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
-4350000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21933000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23368000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20047000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23548000
CY2019 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
900000
CY2017 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
2297000
CY2018Q2 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
372000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23368000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23548000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1435000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
180000
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1886000
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.80
CY2018 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.92
CY2019 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.14
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
150000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
149000
CY2017 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Sale Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent
0
CY2019 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Sale Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent
2870000
CY2018 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Sale Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent
0
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
3771000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4651000
CY2017 us-gaap Costs And Expenses
CostsAndExpenses
323434000
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
369495000
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
352248000
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
10896000
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
6556000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
8996000
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1199000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2473000
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1564000
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
9332000
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
5357000
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
6523000
CY2018Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
9012000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
10071000
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-5233000
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
3730000
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4864000
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4813000
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
11488000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
34834000
CY2019Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
0
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2159000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2476000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
24763000
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
921000
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
369000
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
1042000
CY2019Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
10071000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1964000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1842000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
0
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
840000
CY2018Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
9012000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
600000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
514000
CY2018Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
11309000
CY2019Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
13195000
CY2019Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
223000
CY2018Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
179000
CY2017 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2018 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2019 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.5
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9755000
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9710000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10095000
CY2019 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
14555000
CY2017 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
10066000
CY2018 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
11664000
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
1.31
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
1.76
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
2.45
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.55
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.39
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.13
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.27
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.85
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.43
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.48
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.66
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.020
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.016
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.022
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.037
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.038
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.037
CY2017 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
0.040
CY2018 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
0.017
CY2019 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
0.016
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.001
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.000
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.000
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Percent
EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent
-0.153
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Percent
EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent
0.000
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Percent
EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent
0.000
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Amount
EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount
0
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Amount
EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Amount
EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount
-4325000
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.213
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.254
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.246
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
21726000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
19340000
CY2019Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
54942000
CY2018Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
52611000
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1846000
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2017 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2019 us-gaap Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
7325000
CY2018 us-gaap Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
0
CY2019 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
31330000
CY2018 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
19778000
CY2018Q4 us-gaap Goodwill
Goodwill
293525000
CY2019Q4 us-gaap Goodwill
Goodwill
317676000
CY2017Q4 us-gaap Goodwill
Goodwill
271338000
CY2018 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
2409000
CY2019 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
146000
CY2018 us-gaap Gross Profit
GrossProfit
101663000
CY2017 us-gaap Gross Profit
GrossProfit
90617000
CY2019 us-gaap Gross Profit
GrossProfit
112474000
CY2019Q1 us-gaap Gross Profit
GrossProfit
26718000
CY2019Q4 us-gaap Gross Profit
GrossProfit
26959000
CY2018Q1 us-gaap Gross Profit
GrossProfit
23214000
CY2018Q3 us-gaap Gross Profit
GrossProfit
26076000
CY2018Q2 us-gaap Gross Profit
GrossProfit
27154000
CY2018Q4 us-gaap Gross Profit
GrossProfit
25219000
CY2019Q3 us-gaap Gross Profit
GrossProfit
27372000
CY2019Q2 us-gaap Gross Profit
GrossProfit
31425000
CY2019 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
300000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
33756000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
60211000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
70906000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13647000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6032000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11369000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
9710000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
11274000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
9900000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
743000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1185000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
560000
CY2018 us-gaap Income Tax Reconciliation Deductions
IncomeTaxReconciliationDeductions
806000
CY2019 us-gaap Income Tax Reconciliation Deductions
IncomeTaxReconciliationDeductions
871000
CY2017 us-gaap Income Tax Reconciliation Deductions
IncomeTaxReconciliationDeductions
1139000
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1060000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2059000
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1722000
CY2019 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
0
CY2018 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
0
CY2017 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-24000
CY2019Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
12375000
CY2019Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
13069000
CY2019Q4 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
12015000
CY2018Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
13236000
CY2018Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
10054000
CY2018Q4 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
13673000
CY2018Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
11879000
CY2019Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
19800000
CY2017 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
8543000
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9856000
CY2018 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9183000
CY2019Q4 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
7929000
CY2019Q2 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
14620000
CY2019Q1 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
8443000
CY2018Q3 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
8102000
CY2018Q2 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
9246000
CY2019Q3 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
9047000
CY2018Q4 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
10408000
CY2018Q1 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
7117000
CY2019 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
2499000
CY2017 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
3022000
CY2018 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
1087000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3434000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3447000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6376000
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6979000
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4209000
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4876000
CY2018 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-345000
CY2018 us-gaap Labor And Related Expense
LaborAndRelatedExpense
259228000
CY2017 us-gaap Labor And Related Expense
LaborAndRelatedExpense
237067000
CY2019 us-gaap Lease Cost
LeaseCost
37511000
CY2017 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2086000
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1878000
CY2019 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1020000
CY2018 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
32000
CY2017 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
456000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
52588000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
48828000
CY2018 us-gaap Interest And Other Income
InterestAndOtherIncome
93000
CY2019 us-gaap Interest And Other Income
InterestAndOtherIncome
46000
CY2017 us-gaap Interest And Other Income
InterestAndOtherIncome
88000
CY2018 us-gaap Interest Expense
InterestExpense
2042000
CY2019 us-gaap Interest Expense
InterestExpense
2079000
CY2017 us-gaap Interest Expense
InterestExpense
21060000
CY2018 us-gaap Interest Expense On Prepetition Liabilities Recognized In Statement Of Operations
InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
0
CY2017 us-gaap Interest Expense On Prepetition Liabilities Recognized In Statement Of Operations
InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
0
CY2019 us-gaap Interest Expense On Prepetition Liabilities Recognized In Statement Of Operations
InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
0
CY2017 us-gaap Interest Paid Net
InterestPaidNet
2113000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
2357000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
1890000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
6129000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
29279000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
11528000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
6453000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
93797000
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7053000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
17039000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
23369000
CY2019 us-gaap Labor And Related Expense
LaborAndRelatedExpense
274233000
CY2018Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
31712000
CY2019Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
33247000
CY2018Q4 us-gaap Liabilities
Liabilities
92348000
CY2019Q4 us-gaap Liabilities
Liabilities
181394000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
443166000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
560845000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
60563000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
41946000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
51089000
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
39836000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
50361000
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
38402000
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
728000
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
728000
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1434000
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
50361000
CY2018Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
402000
CY2019Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
4361000
CY2018Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
38000000
CY2019Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
46000000
CY2018 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
5812000
CY2019 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
6014000
CY2017 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
5300000
CY2018Q4 us-gaap Minority Interest
MinorityInterest
930000
CY2019Q4 us-gaap Minority Interest
MinorityInterest
1444000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
56526000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
62448000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
73005000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-43575000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23909000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-37993000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11065000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-24275000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-47661000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
22256000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
40039000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
34873000
CY2017 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
5468000
CY2018 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
13969000
CY2019 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
17220000
CY2019 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
502000
CY2018 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
0
CY2017 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
0
CY2019 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2019Q4 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
40
CY2017 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
2
CY2019 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
1
CY2018 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
5
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y0M18D
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
81586000
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
30225000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
34800000
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
37100000
CY2019 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
37500000
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.039
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
54728000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
67425000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
60314000
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
15286000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
17026000
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
14804000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
15433000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
13051000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
19898000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
16816000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
15425000
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
26486000
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
60258000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
30077000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
86744000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
28022000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
8302000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
14332000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
20618000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
115490000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
35784000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
8432000
CY2018 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
167000
CY2018 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
16367000
CY2019 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
30597000
CY2019 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
10189000
CY2018 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
350000
CY2017 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
621000
CY2019 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
96000
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4353000
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
5787000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1430000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1519000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
141000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
829000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6350000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4935000
CY2018 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
265000
CY2019 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
0
CY2017 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
2361000
CY2019 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
14555000
CY2017 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
10066000
CY2018 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
11664000
CY2017 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
36682000
CY2018Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
16367000
CY2019Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
30597000
CY2018 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
15646000
CY2017 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
5572000
CY2019 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
16235000
CY2017 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
7095000
CY2018 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
7193000
CY2019 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
428000
CY2017 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
0
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
45049000
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
35889000
CY2019 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-52000
CY2018 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2017 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
161000
CY2018 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-42000
CY2019 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
11601000
CY2017 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0
CY2019 us-gaap Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates
ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
207000
CY2018 us-gaap Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates
ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
0
CY2017 us-gaap Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates
ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
121000
CY2018 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
103000000
CY2017 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
93000000
CY2019 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
145000000
CY2019 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
64000
CY2017 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
81000
CY2018 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1000
CY2019 us-gaap Profit Loss
ProfitLoss
57259000
CY2018 us-gaap Profit Loss
ProfitLoss
48842000
CY2017 us-gaap Profit Loss
ProfitLoss
27724000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
84323000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
88189000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20169000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22090000
CY2017 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3672000
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4603000
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4858000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
113222000
CY2019Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
137750000
CY2018Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
133943000
CY2017 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
85000000
CY2019 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
137000000
CY2017 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1227000
CY2018 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
4044000
CY2019 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1433000
CY2018 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
119000000
CY2019 us-gaap Restructuring Charges
RestructuringCharges
25000
CY2018 us-gaap Restructuring Charges
RestructuringCharges
-9000
CY2017 us-gaap Restructuring Charges
RestructuringCharges
599000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
184352000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
167396000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
481969000
CY2017 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
414051000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
453911000
CY2018Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
117349000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
116231000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
126373000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
117251000
CY2018Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108342000
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
122114000
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
115098000
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
113122000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
0
CY2018 usph Net Income Loss Attributable To Noncontrolling Interest Permanent Equity
NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
5536000
CY2019 usph Purchase Of Partnership Interests Redeemable Non Controlling Interests
PurchaseOfPartnershipInterestsRedeemableNonControllingInterests
-292000
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
41349000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
5939000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
5032000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
6985000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2700000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
309480
CY2008Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
2250000
CY2018 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
CY2017 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
CY2019 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
CY2009Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
859499
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2019Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
114.35
CY2019 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1212000
CY2009Q1 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
1200000
CY2019 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
CY2018 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
CY2019 us-gaap Stockholders Equity Other
StockholdersEquityOther
40000
CY2018 us-gaap Stockholders Equity Other
StockholdersEquityOther
99000
CY2017 us-gaap Stockholders Equity Other
StockholdersEquityOther
160000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
240257000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
215945000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
241701000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
216875000
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
188688000
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
206070000
CY2017 us-gaap Tax Cuts And Jobs Act Of2017 Change In Tax Rate Deferred Tax Liability Income Tax Benefit
TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxLiabilityIncomeTaxBenefit
-4300000
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2214737
CY2018Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2214737
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
31628000
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
31628000
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2018Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2017Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2019 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
0
CY2018 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
0
CY2017 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
0
CY2018 usph Charges To Retained Earnings Revaluation Of Non Controlling Interests
ChargesToRetainedEarningsRevaluationOfNonControllingInterests
-24770000
CY2019 usph Number Of Partnership In Which Interest Acquired
NumberOfPartnershipInWhichInterestAcquired
4
CY2019 usph Net Income Loss Attributable To Noncontrolling Interest Permanent Equity
NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
6561000
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12685000
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12707000
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-style: italic; font-weight: bold;">Use of Estimates</div><div><br /></div><div style="text-indent: 20pt;">In preparing the Company&#8217;s consolidated financial statements, management makes certain estimates and assumptions, especially in relation to, but not limited to, goodwill impairment, tradenames, allocations of purchase price, allowance for receivables, tax provision and contractual allowances, that affect the amounts reported in the consolidated financial statements and related disclosures. Actual results may differ from these estimates.</div></div>
CY2019 us-gaap Variable Lease Cost
VariableLeaseCost
6074000
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12570000
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12756000
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12666000
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12616000
CY2019Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12774000
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12774000
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12677000
CY2018Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12685000
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12767000
CY2018 usph Increase Decrease In Mandatorily Redeemable Non Controlling Interests
IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests
0
CY2017 usph Increase Decrease In Mandatorily Redeemable Non Controlling Interests
IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests
11579000
CY2019 usph Increase Decrease In Mandatorily Redeemable Non Controlling Interests
IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests
0
CY2017 usph Gain On Sale Of Partnership Interest Net Of Tax
GainOnSaleOfPartnershipInterestNetOfTax
0
CY2018 usph Gain On Sale Of Partnership Interest Net Of Tax
GainOnSaleOfPartnershipInterestNetOfTax
0
CY2019 usph Gain On Sale Of Partnership Interest Net Of Tax
GainOnSaleOfPartnershipInterestNetOfTax
5514000
CY2019 usph Payments To Acquire Redeemable Non Controlling Interest
PaymentsToAcquireRedeemableNonControllingInterest
8651000
CY2017 usph Payments To Acquire Redeemable Non Controlling Interest
PaymentsToAcquireRedeemableNonControllingInterest
0
CY2018 usph Payments To Acquire Redeemable Non Controlling Interest
PaymentsToAcquireRedeemableNonControllingInterest
0
CY2018 usph Purchase Of Business Seller Financing Portion
PurchaseOfBusinessSellerFinancingPortion
950000
CY2017 usph Purchase Of Business Seller Financing Portion
PurchaseOfBusinessSellerFinancingPortion
2150000
CY2019 usph Purchase Of Business Seller Financing Portion
PurchaseOfBusinessSellerFinancingPortion
4300000
CY2019Q4 usph Notes Payable Related To Purchase Of Redeemable Non Controlling Interest Temporary Equity
NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity
283000
CY2017Q4 usph Notes Payable Related To Purchase Of Redeemable Non Controlling Interest Temporary Equity
NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity
0
CY2018Q4 usph Notes Payable Related To Purchase Of Redeemable Non Controlling Interest Temporary Equity
NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity
0
CY2017Q4 usph Notes Payable Related To Purchase Of Non Controlling Interest Permanent Equity
NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity
0
CY2019Q4 usph Notes Payable Related To Purchase Of Non Controlling Interest Permanent Equity
NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity
103000
CY2018Q4 usph Notes Payable Related To Purchase Of Non Controlling Interest Permanent Equity
NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity
0
CY2018 usph Revaluation Of Redeemable Non Controlling Interest Net Of Tax
RevaluationOfRedeemableNonControllingInterestNetOfTax
-18268000
CY2017 usph Revaluation Of Redeemable Non Controlling Interest Net Of Tax
RevaluationOfRedeemableNonControllingInterestNetOfTax
-126000
CY2019 usph Revaluation Of Redeemable Non Controlling Interest Net Of Tax
RevaluationOfRedeemableNonControllingInterestNetOfTax
-8771000
CY2019 usph Sale Of Non Controlling Interest Net Of Tax And Purchases
SaleOfNonControllingInterestNetOfTaxAndPurchases
196000
CY2017 usph Sale Of Non Controlling Interest Net Of Tax And Purchases
SaleOfNonControllingInterestNetOfTaxAndPurchases
36000
CY2018 usph Sale Of Non Controlling Interest Net Of Tax And Purchases
SaleOfNonControllingInterestNetOfTaxAndPurchases
-272000
CY2018 usph Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans
TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
373000
CY2019 usph Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans
TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
636000
CY2017 usph Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans
TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
165000
CY2017 usph Net Income Loss Attributable To Noncontrolling Interest Permanent Equity
NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
5224000
CY2017 usph Interest Expense Debt And Other
InterestExpenseDebtAndOther
2111000
CY2019 usph Interest Expense Debt And Other
InterestExpenseDebtAndOther
2079000
CY2019Q2 usph Business Acquisition Cost Of Acquired Entity Debt Issued
BusinessAcquisitionCostOfAcquiredEntityDebtIssued
4300000
CY2017Q4 usph Business Acquisition Cost Of Acquired Entity Debt Issued
BusinessAcquisitionCostOfAcquiredEntityDebtIssued
2150000
CY2018 usph Interest Expense Debt And Other
InterestExpenseDebtAndOther
2042000
CY2019 usph Interest Expense Mandatorily Redeemable Non Controlling Interests Increase Decrease In Redemption Value
InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue
0
CY2017 usph Interest Expense Mandatorily Redeemable Non Controlling Interests Increase Decrease In Redemption Value
InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue
12894000
CY2018 usph Interest Expense Mandatorily Redeemable Non Controlling Interests Increase Decrease In Redemption Value
InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue
0
CY2019 usph Rent Supplies Contract Labor And Other
RentSuppliesContractLaborAndOther
90379000
CY2018 usph Rent Supplies Contract Labor And Other
RentSuppliesContractLaborAndOther
88426000
CY2017 usph Rent Supplies Contract Labor And Other
RentSuppliesContractLaborAndOther
82096000
CY2017 usph Interest Expense Mandatorily Redeemable Non Controlling Interests Earnings Allocable
InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable
6055000
CY2018 usph Interest Expense Mandatorily Redeemable Non Controlling Interests Earnings Allocable
InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable
0
CY2019 usph Interest Expense Mandatorily Redeemable Non Controlling Interests Earnings Allocable
InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable
0
CY2018 usph Gain On Sale Of Partnership Interest
GainOnSaleOfPartnershipInterest
0
CY2019 usph Gain On Sale Of Partnership Interest
GainOnSaleOfPartnershipInterest
5514000
CY2017 usph Gain On Sale Of Partnership Interest
GainOnSaleOfPartnershipInterest
0
CY2018 usph Net Income Loss Attributable To Redeemable Noncontrolling Interest Temporary Equity
NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
8433000
CY2019 usph Net Income Loss Attributable To Redeemable Noncontrolling Interest Temporary Equity
NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
10659000
CY2017 usph Net Income Loss Attributable To Redeemable Noncontrolling Interest Temporary Equity
NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
244000
CY2018Q4 usph Patients And Payors Related Liability
PatientsAndPayorsRelatedLiability
7293000
CY2019Q4 usph Patients And Payors Related Liability
PatientsAndPayorsRelatedLiability
4303000
CY2019 usph Effective Income Tax Rate Reconciliation At Federal And State Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate
0.2625
CY2017 usph Income Tax Reconciliation Income Tax Expense Benefit At Federal And State Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
-75000
CY2018 usph Income Tax Reconciliation Income Tax Expense Benefit At Federal And State Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
-6502000
CY2019 usph Income Tax Reconciliation Income Tax Expense Benefit At Federal And State Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
-3121000
CY2018 usph Income Loss From Operations After Revaluation Of Non Controlling Interests
IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests
16605000
CY2019 usph Income Loss From Operations After Revaluation Of Non Controlling Interests
IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests
31267000
CY2017 usph Income Loss From Operations After Revaluation Of Non Controlling Interests
IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests
22130000
CY2019 usph Charges To Retained Earnings Revaluation Of Non Controlling Interests
ChargesToRetainedEarningsRevaluationOfNonControllingInterests
-11893000
CY2017 usph Charges To Retained Earnings Revaluation Of Non Controlling Interests
ChargesToRetainedEarningsRevaluationOfNonControllingInterests
-201000
CY2019 usph Combined Physical Therapy Speech Language Pathology Expenses
CombinedPhysicalTherapySpeechLanguagePathologyExpenses
3700
CY2017 usph Number Of Partnership In Which Interest Acquired
NumberOfPartnershipInWhichInterestAcquired
2
CY2018 usph Number Of Partnership In Which Interest Acquired
NumberOfPartnershipInWhichInterestAcquired
3
CY2019 usph Sale Of Noncontrolling Interest Percentage In Partnership One
SaleOfNoncontrollingInterestPercentageInPartnershipOne
0.01
CY2017 usph Tax Effect On Sale Of Noncontrolling Interest
TaxEffectOnSaleOfNoncontrollingInterest
56000
CY2019 usph Tax Effect On Sale Of Noncontrolling Interest
TaxEffectOnSaleOfNoncontrollingInterest
196000
CY2018 usph Tax Effect On Sale Of Noncontrolling Interest
TaxEffectOnSaleOfNoncontrollingInterest
224000
CY2019Q4 usph Share Based Compensation Arrangement By Share Based Payment Award Options Exercises For The Cumulative Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod
918091
CY2019Q4 usph Share Based Compensation Arrangement By Share Based Payment Award Restricted Stock Grants For The Cumulative Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod
1436397
CY2019Q4 usph Deferred Tax Assets Lease Obligations
DeferredTaxAssetsLeaseObligations
21445000
CY2018Q4 usph Deferred Tax Assets Lease Obligations
DeferredTaxAssetsLeaseObligations
34000
CY2019Q4 usph Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
21416000
CY2018Q4 usph Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
0
CY2018 usph Net Revenue From Medicare
NetRevenueFromMedicare
103600000
CY2019 usph Percentage Of Payment For Outpatient Therapy Services
PercentageOfPaymentForOutpatientTherapyServices
0.85
CY2019 usph Number Of Regions
NumberOfRegions
6
CY2017 usph Number Of Regions
NumberOfRegions
6
CY2018 usph Number Of Regions
NumberOfRegions
6
CY2019 usph Percentage Of Practice Expense Component Of Relative Value Unit
PercentageOfPracticeExpenseComponentOfRelativeValueUnit
1
CY2019 usph Amount Of Reductions In Federal Spending
AmountOfReductionsInFederalSpending
1200000000000
CY2017 usph Net Revenue From Medicare
NetRevenueFromMedicare
92600000
CY2019 usph Net Revenue From Medicare
NetRevenueFromMedicare
119400000
CY2019 usph Maximum Contractual Allowance Reserve Estimate
MaximumContractualAllowanceReserveEstimate
0.01
CY2019 usph Difference Between Actual Aggregate Contractual Reserve Percentages As Compared To Estimated Contractual Allowance Reserve Percentage
DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage
0.01
CY2015Q4 usph Expected Reduction In Medicare Spending Percentage
ExpectedReductionInMedicareSpendingPercentage
0.02
CY2018Q1 usph Expected Reduction In Medicare Spending Percentage
ExpectedReductionInMedicareSpendingPercentage
0.02
CY2013Q2 usph Expected Reduction In Medicare Spending Percentage
ExpectedReductionInMedicareSpendingPercentage
0.02
CY2019 usph Difference Between Net Revenues And Corresponding Cash Collections Reflected Percentage Of Net Revenues
DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues
0.01
CY2019 usph Percentage Reduction For Service In Office Or Other Non Institutional Settings
PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings
0.5
CY2019 usph Reduction In Medicare Spending Percentage
ReductionInMedicareSpendingPercentage
0.02
CY2019 usph Reduction In Combined Physical Therapy Speech Language Pathology Expenses
ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses
3000
CY2019 usph Period Of Federal Debt Ceiling In Connection With Deficit Reductions
PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions
P10Y
CY2019Q4 usph Deferred Tax Assets Related To Redeemable Non Controlling Interests And Acquisitions Of Non Controlling Interests
DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests
3000000
CY2019Q4 usph Share Based Compensation Arrangement By Share Based Payment Award For Shares Outstanding Restrictions Had Not Lapsed
ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed
150771
CY2018Q4 usph Share Based Compensation Arrangement By Share Based Payment Award For Shares Outstanding Restrictions Had Not Lapsed
ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed
152926
CY2019 usph Defined Contribution Plan Period For New Employees Covered Under Plan
DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan
P3M
CY2017 usph Defined Contribution Plan Employer Matching Contribution Amount
DefinedContributionPlanEmployerMatchingContributionAmount
1500000
CY2019 usph Defined Contribution Plan Employer Matching Contribution Amount
DefinedContributionPlanEmployerMatchingContributionAmount
2000000
CY2018 usph Defined Contribution Plan Employer Matching Contribution Amount
DefinedContributionPlanEmployerMatchingContributionAmount
1800000
CY2019Q2 usph Business Acquisition Payable To Shareholders Of Seller
BusinessAcquisitionPayableToShareholdersOfSeller
486000
CY2019 usph Percentage Of General Partnership Interest Owned
PercentageOfGeneralPartnershipInterestOwned
0.01
CY2019 usph Number Of Third Party Facilities
NumberOfThirdPartyFacilities
26
CY2018Q2 usph Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Referral Relationships
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships
2926000
CY2019Q2 usph Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Tradename
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename
4100000
CY2019Q4 usph Number Of Clinics Operated
NumberOfClinicsOperated
583
CY2018Q2 usph Business Acquisition Cost Of Acquired Entity Debt Issued
BusinessAcquisitionCostOfAcquiredEntityDebtIssued
950000
CY2019Q2 usph Payments To Acquire Businesses Consideration
PaymentsToAcquireBusinessesConsideration
35383000
CY2018Q2 usph Payments To Acquire Businesses Consideration
PaymentsToAcquireBusinessesConsideration
17317000
CY2017Q4 usph Payments To Acquire Businesses Consideration
PaymentsToAcquireBusinessesConsideration
38832000
CY2017Q4 usph Business Combination Acquisition Fair Value Of Redeemable Non Controlling Interests
BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests
13883000
CY2019Q2 usph Business Combination Acquisition Fair Value Of Redeemable Non Controlling Interests
BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests
6230000
CY2018Q2 usph Business Combination Acquisition Fair Value Of Redeemable Non Controlling Interests
BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests
8145000
CY2018Q2 usph Business Acquisition Purchase Price Allocation Net Tangible Asset
BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset
1413000
CY2019Q2 usph Business Acquisition Purchase Price Allocation Net Tangible Asset
BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset
1893000
CY2017Q4 usph Business Acquisition Purchase Price Allocation Net Tangible Asset
BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset
4515000
CY2017Q4 usph Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Referral Relationships
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships
4250000
CY2019Q2 usph Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Referral Relationships
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships
3000000
CY2018Q2 usph Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Tradename
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename
990000
CY2017Q4 usph Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Tradename
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename
6850000
CY2018 usph Number Of Clinics Operates As A Satellite Clinic With Existing Partnerships
NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships
1
CY2019 usph Number Of Clinics Operates As A Satellite Clinic With Existing Partnerships
NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships
1
CY2017 usph Number Of Clinics Operates As A Satellite Clinic With Existing Partnerships
NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships
1
CY2018 usph Number Of Clinics Consolidated With Existing Clinics
NumberOfClinicsConsolidatedWithExistingClinics
1
CY2017 usph Number Of Clinics Consolidated With Existing Clinics
NumberOfClinicsConsolidatedWithExistingClinics
1
CY2018Q2 usph Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Non Competition Agreements
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements
298000
CY2017Q4 usph Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Non Competition Agreements
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements
660000
CY2019Q2 usph Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Non Competition Agreements
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements
1290000
CY2019Q4 usph Employee Compensation Future Payment Due Next Fiscal Year
EmployeeCompensationFuturePaymentDueNextFiscalYear
39300000
CY2019 usph Renewal Period For Employment Agreement
RenewalPeriodForEmploymentAgreement
P2Y
CY2019Q4 usph Employee Compensation Future Payment Due Next Fiscal Year Thereafter
EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter
8600000
CY2019 usph Employment Agreements Expiration Date
EmploymentAgreementsExpirationDate
2020-12-31
CY2019 usph Employment Agreements Retirement Date
EmploymentAgreementsRetirementDate
2020-10-31
CY2019 usph Additional Estimated Repurchase Of Common Stock
AdditionalEstimatedRepurchaseOfCommonStock
131176

Files In Submission

Name View Source Status
0001140361-20-004374-index-headers.html Edgar Link pending
0001140361-20-004374-index.html Edgar Link pending
0001140361-20-004374.txt Edgar Link pending
0001140361-20-004374-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hc10009190x1_10k.htm Edgar Link pending
hc10009190x1_ex21-1.htm Edgar Link pending
hc10009190x1_ex23-1.htm Edgar Link pending
hc10009190x1_ex31-1.htm Edgar Link pending
hc10009190x1_ex31-2.htm Edgar Link pending
hc10009190x1_ex31-3.htm Edgar Link pending
hc10009190x1_ex32-1.htm Edgar Link pending
hc10009190x1_ex4-1.htm Edgar Link pending
hc10009190x1_lchart01.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
usph-20191231.xml Edgar Link completed
usph-20191231.xsd Edgar Link pending
usph-20191231_cal.xml Edgar Link unprocessable
usph-20191231_def.xml Edgar Link unprocessable
usph-20191231_lab.xml Edgar Link unprocessable
usph-20191231_pre.xml Edgar Link unprocessable